NCT03599518 2023-02-08
DS-1205c With Gefitinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
Daiichi Sankyo
Phase 1 Terminated
Daiichi Sankyo
University of California, San Francisco
National Cancer Institute (NCI)